1. Home
  2. ABT vs PEP Comparison

ABT vs PEP Comparison

Compare ABT & PEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABT
  • PEP
  • Stock Information
  • Founded
  • ABT 1888
  • PEP 1898
  • Country
  • ABT United States
  • PEP United States
  • Employees
  • ABT N/A
  • PEP N/A
  • Industry
  • ABT Medical/Dental Instruments
  • PEP Beverages (Production/Distribution)
  • Sector
  • ABT Health Care
  • PEP Consumer Staples
  • Exchange
  • ABT Nasdaq
  • PEP Nasdaq
  • Market Cap
  • ABT 233.7B
  • PEP 205.9B
  • IPO Year
  • ABT N/A
  • PEP N/A
  • Fundamental
  • Price
  • ABT $132.69
  • PEP $149.02
  • Analyst Decision
  • ABT Strong Buy
  • PEP Buy
  • Analyst Count
  • ABT 19
  • PEP 14
  • Target Price
  • ABT $142.79
  • PEP $156.92
  • AVG Volume (30 Days)
  • ABT 5.3M
  • PEP 7.7M
  • Earning Date
  • ABT 10-15-2025
  • PEP 10-09-2025
  • Dividend Yield
  • ABT 1.78%
  • PEP 3.83%
  • EPS Growth
  • ABT 151.50
  • PEP N/A
  • EPS
  • ABT 7.97
  • PEP 5.49
  • Revenue
  • ABT $43,109,000,000.00
  • PEP $91,748,000,000.00
  • Revenue This Year
  • ABT $7.60
  • PEP $2.38
  • Revenue Next Year
  • ABT $7.84
  • PEP $3.12
  • P/E Ratio
  • ABT $16.64
  • PEP $27.08
  • Revenue Growth
  • ABT 5.85
  • PEP N/A
  • 52 Week Low
  • ABT $110.86
  • PEP $127.60
  • 52 Week High
  • ABT $141.23
  • PEP $179.73
  • Technical
  • Relative Strength Index (RSI)
  • ABT 53.33
  • PEP 56.01
  • Support Level
  • ABT $130.14
  • PEP $146.23
  • Resistance Level
  • ABT $133.62
  • PEP $148.04
  • Average True Range (ATR)
  • ABT 1.91
  • PEP 2.20
  • MACD
  • ABT 0.07
  • PEP -0.53
  • Stochastic Oscillator
  • ABT 62.77
  • PEP 31.24

About ABT Abbott Laboratories

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

About PEP PepsiCo Inc.

PepsiCo is a global leader in snacks and beverages, owning well-known household brands including Pepsi, Mountain Dew, Gatorade, Lay's, Cheetos, and Doritos, among others. The company dominates the global savory snacks market and also ranks as the second-largest beverage provider in the world (behind Coca-Cola) with diversified exposure to carbonated soft drinks, or CSD, as well as water, sports, and energy drink offerings. Convenience foods account for approximately 55% of its total revenue, with beverages making up the rest. Pepsi owns the bulk of its manufacturing and distribution capacity in the US, but uses bottlers overseas for beverages. International markets made up 40% of both total sales and operating profits in 2024.

Share on Social Networks: